NCT05088096

Brief Summary

A reliability and validity study for the cross culturally adapted and translated version of Upper limb musculoskeletal index questionnaire into Urdu language. This can be used for the reporting of upper limb musculoskeletal disorders including hand, shoulder and arm pathologies, carpel tunnel syndrome, osteoarthritis etc.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 5, 2021

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 9, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 21, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 5, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 5, 2022

Completed
Last Updated

June 9, 2023

Status Verified

June 1, 2023

Enrollment Period

1.1 years

First QC Date

October 9, 2021

Last Update Submit

June 7, 2023

Conditions

Keywords

TranslationMusculoskeletal injuryUpper limb

Outcome Measures

Primary Outcomes (2)

  • Cross cultural adaptation, translation, reliability and validity of Upper limb functional Index in patients with musculoskeletal disorders

    Upper limb musculoskeletal disorder index will be translated into Urdu and will be cross culturally adapt throughout.

    1 week

  • Cross cultural adaptation, translation, reliability and validity of Upper limb functional index (ULFI)

    It will be assessed for reliability and validity.

    1 week

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Subjects with upper limb musculoskeletal disorders will be enrolled in the study with age limits from 18-40 years. Data will be entered for the first and then after a duration of few days for reliability and validity of questionairre.

You may qualify if:

  • Both male and female patients will be included.
  • Sub-acute or chronic conditions of upper limb musculoskeletal disorders.
  • Musculoskeletal disorders such as carpal tunnel syndrome (CTS), tendonitis or tenosynovitis, osteoarthritis, cramp of the hand or forearm from prolonged periods of repetitive movement, hand-arm vibration syndrome (HAVS).
  • Patients with unilateral disorders will be included.

You may not qualify if:

  • Presence of other significant rheumatic disease variants.
  • Severe inflammatory arthritis as confirmed by physical examination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ayesha Arooj

Lahore, Punjab Province, 54000, Pakistan

Location

Related Publications (1)

  • Arooj A, Amjad F, Tanveer F, Arslan AU, Ahmad A, Gilani SA. Translation, cross-cultural adaptation and psychometric properties of Urdu version of upper limb functional index; a validity and reliability study. BMC Musculoskelet Disord. 2022 Jul 20;23(1):691. doi: 10.1186/s12891-022-05628-8.

Study Officials

  • Fareeha Amjad

    University of Lahore

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
2 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 9, 2021

First Posted

October 21, 2021

Study Start

March 5, 2021

Primary Completion

April 5, 2022

Study Completion

April 5, 2022

Last Updated

June 9, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations